| Whole-genome sequencing of patients with rare diseases in a national health system E Turro, WJ Astle, K Megy, S Gräf, D Greene, O Shamardina, HL Allen, ... Nature 583 (7814), 96-102, 2020 | 501 | 2020 |
| A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia MC Di Bernardo, D Crowther-Swanepoel, P Broderick, E Webb, G Sellick, ... Nature genetics 40 (10), 1204-1210, 2008 | 466 | 2008 |
| Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease KJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ... The American Journal of Human Genetics 100 (1), 75-90, 2017 | 465 | 2017 |
| RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19 P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ... N Engl J Med 384 (8), 693-704, 2021 | 352 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 288 | 2022 |
| Common variants at 2q37. 3, 8q24. 21, 15q21. 3 and 16q24. 1 influence chronic lymphocytic leukemia risk D Crowther-Swanepoel, P Broderick, MC Di Bernardo, SE Dobbins, ... Nature genetics 42 (2), 132-136, 2010 | 284 | 2010 |
| Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of … AR Pettitt, R Jackson, S Carruthers, J Dodd, S Dodd, M Oates, ... Journal of Clinical Oncology 30 (14), 1647-1655, 2012 | 246 | 2012 |
| A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia HE Speedy, MC Di Bernardo, GP Sava, MJS Dyer, A Holroyd, Y Wang, ... Nature genetics 46 (1), 56-60, 2014 | 231 | 2014 |
| Germline selection shapes human mitochondrial DNA diversity W Wei, S Tuna, MJ Keogh, KR Smith, TJ Aitman, PL Beales, DL Bennett, ... Science 364 (6442), eaau6520, 2019 | 214 | 2019 |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort JED Thaventhiran, H Lango Allen, OS Burren, W Rae, D Greene, ... Nature 583 (7814), 90-95, 2020 | 206 | 2020 |
| Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia AS Kamiguti, L Serrander, K Lin, RJ Harris, JC Cawley, DJ Allsup, ... The Journal of Immunology 175 (12), 8424-8430, 2005 | 156 | 2005 |
| Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects B Johnson, GC Lowe, J Futterer, M Lordkipanidzé, D MacDonald, ... haematologica 101 (10), 1170, 2016 | 149 | 2016 |
| Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension C Hadinnapola, M Bleda, M Haimel, N Screaton, A Swift, P Dorfmüller, ... Circulation 136 (21), 2022-2033, 2017 | 141 | 2017 |
| The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research A Smith, E Roman, D Howell, R Jones, R Patmore, A Jack, ... British journal of haematology 148 (5), 739-753, 2010 | 132 | 2010 |
| Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia PJ Law, SI Berndt, HE Speedy, NJ Camp, GP Sava, CF Skibola, ... Nature communications 8 (1), 14175, 2017 | 107 | 2017 |
| Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease TT Lin, K Norris, NH Heppel, G Pratt, JM Allan, DJ Allsup, J Bailey, ... British journal of haematology 167 (2), 214-223, 2014 | 105 | 2014 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 94 | 2021 |
| The kinin–kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers E Kashuba, J Bailey, D Allsup, L Cawkwell Biomarkers 18 (4), 279-296, 2013 | 90 | 2013 |
| Chronic lymphocytic leukemia therapy guided by measurable residual disease T Munir, DA Cairns, A Bloor, D Allsup, K Cwynarski, A Pettitt, S Paneesha, ... New England Journal of Medicine 390 (4), 326-337, 2024 | 82 | 2024 |
| B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia DJ Allsup, AS Kamiguti, K Lin, PD Sherrington, Z Matrai, JR Slupsky, ... Cancer research 65 (16), 7328-7337, 2005 | 81 | 2005 |
Peter HillmenUniversity of LeedsZweryfikowany adres z leeds.ac.uk